Suppr超能文献

基于 sortase A 酶的合成、抗菌活性和分子模拟研究

Synthesis, Antimicrobial Activities, and Molecular Modeling Studies of Agents for the Sortase A Enzyme.

机构信息

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Turkiye.

Department of Pharmacognosy, Faculty of Pharmacy, Karadeniz Technical University, 61080, Trabzon, Turkiye.

出版信息

Chem Biodivers. 2024 May;21(5):e202301659. doi: 10.1002/cbdv.202301659. Epub 2024 Apr 11.

Abstract

Sortase A (SrtA) is an attractive target for developing new anti-infective drugs that aim to interfere with essential virulence mechanisms, such as adhesion to host cells and biofilm formation. Herein, twenty hydroxy, nitro, bromo, fluoro, and methoxy substituted chalcone compounds were synthesized, antimicrobial activities and molecular modeling strategies against the SrtA enzyme were investigated. The most active compounds were found to be T2, T4, and T19 against Streptococcus mutans (S. mutans) with MIC values of 1.93, 3.8, 3.94 μg/mL, and docking scores of -6.46, -6.63, -6.73 kcal/mol, respectively. Also, these three active compounds showed better activity than the chlorohexidine (CHX) (MIC value: 4.88 μg/mL, docking score: -6.29 kcal/mol) in both in vitro and in silico. Structural stability and binding free energy analysis of S.mutans SrtA with active compounds were measured by molecular dynamic (MD) simulations throughout 100 nanoseconds (ns) time. It was observed that the stability of the critical interactions between these compounds and the target enzyme was preserved. To prove further, in vivo biological evaluation studies could be conducted for the most promising precursor compounds T2, T4, and T19, and it might open new avenues to the discovery of more potent SrtA inhibitors.

摘要

天冬酰胺酰基内肽酶 A(SrtA)是开发新型抗感染药物的一个有吸引力的靶点,旨在干扰关键毒力机制,如黏附宿主细胞和生物膜形成。在此,合成了 20 种羟基、硝基、溴基、氟基和甲氧基取代的查尔酮化合物,研究了它们对 SrtA 酶的抗菌活性和分子模拟策略。结果发现,T2、T4 和 T19 对变形链球菌(S. mutans)的活性最强,MIC 值分别为 1.93、3.8 和 3.94μg/mL,对接评分分别为-6.46、-6.63 和-6.73kcal/mol。此外,这三种活性化合物在体外和体内的活性均优于氯己定(CHX)(MIC 值:4.88μg/mL,对接评分:-6.29kcal/mol)。通过分子动力学(MD)模拟 100 纳秒(ns)的时间,测量了 S.mutans SrtA 与活性化合物的结构稳定性和结合自由能。结果表明,这些化合物与靶酶之间的关键相互作用的稳定性得以保留。为了进一步证明,对于最有前途的前体化合物 T2、T4 和 T19,可以进行体内生物评价研究,这可能为发现更有效的 SrtA 抑制剂开辟新途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验